STOCK TITAN
  1. Home
  2. Sec-filings
  3. BTAI
  4. [Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity

[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock BTAI logo
Bioxcel Therapeutics Inc

NASDAQ:BTAI

BTAI Rankings

#9870 Ranked by Market Cap
N/A Ranked by Dividends

BTAI Latest News

Jul 21, 2025
BioXcel Therapeutics Submits Pre-Supplemental New Drug Application Meeting Package in Support of Potential Label Expansion for IGALMI®
Jul 1, 2025
BioXcel Therapeutics Receives Second Positive Recommendation from Data Safety Monitoring Board (DSMB) to Continue SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
May 27, 2025
BioXcel Therapeutics Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) to Continue SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
May 27, 2025
BioXcel Therapeutics Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirement
May 12, 2025
BioXcel Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

BTAI Latest SEC Filings

Jul 22, 2025
[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity
Jul 22, 2025
[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity
Jul 22, 2025
[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity
Jul 21, 2025
[8-K] BioXcel Therapeutics, Inc. Reports Material Event
Jul 15, 2025
[8-K] BioXcel Therapeutics, Inc. Reports Material Event

BTAI Stock Data

11.51M
5.53M
15.38%
13.97%
10.31%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN